SavedAdd your journal

Journals / Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) / 2017 / Cilt: 28 - Sayı: 1

Eklem içi tranekzamik asit enjeksiyonunun primer total diz artoplastisindekan transfüzyonu oranlarını azaltmasından başka faydalar

Other benefits of intra-articular injection of tranexamic acid in primary total knee arthroplasty apart from reducing blood transfusion rates

Mehmet Ali ACAR
Ömer Faruk ERKOÇAK
Bahattin Kerem AYDIN
Fatih DURGUT
Pages
25–29
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The maximum difference between pre- and postoperative hemoglobin levels, the amount of blood in the drains, the amount of blood transfusion, length of hospital stay, and cost of each patient were recorded.Results: The mean difference between pre- and postoperative hemoglobin levels were higher in the non-TA group (1.7 g/dL vs 2.6 g/dL, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to evaluate the effect of intraarticular tranexamic acid (TA) administration on the amount of blood in the drains, the amount of blood transfusion, length of hospital stay, and the total cost in total knee arthroplasty (TKA) patients.Patients and methods: The study included a total of 118 patients (24 males, 94 females; mean age 67.0 years, range 52 to 81 years) who underwent primary unilateral TKA surgery.
📊
Key Findings & Data:Patients were divided into two groups as 58 patients who were performed intra-articular injection of 2 g TA after closure of articular capsule (TA group; 10 males, 48 females, mean age 65.6 years; range 55 to 80 years) and 60 patients who were not performed any intra-articular injection (non-TA group; 14 males, 46 females; mean age 68.3 years; range 52 to 81 years).
💡
Conclusion & Impact:The maximum difference between pre- and postoperative hemoglobin levels, the amount of blood in the drains, the amount of blood transfusion, length of hospital stay, and cost of each patient were recorded.Results: The mean difference between pre- and postoperative hemoglobin levels were higher in the non-TA group (1.7 g/dL vs 2.6 g/dL, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to evaluate the effect of intraarticular tranexamic acid (TA) administration on the amount of blood in the drains, the amount of blood transfusion, length of hospital stay, and the total cost in total knee arthroplasty (TKA) patients.Patients and methods: The study included a total of 118 patients (24 males, 94 females; mean age 67.0 years, range 52 to 81 years) who underwent primary unilateral TKA surgery. Patients were divided into two groups as 58 patients who were performed intra-articular injection of 2 g TA after closure of articular capsule (TA group; 10 males, 48 females, mean age 65.6 years; range 55 to 80 years) and 60 patients who were not performed any intra-articular injection (non-TA group; 14 males, 46 females; mean age 68.3 years; range 52 to 81 years). The maximum difference between pre- and postoperative hemoglobin levels, the amount of blood in the drains, the amount of blood transfusion, length of hospital stay, and cost of each patient were recorded.Results: The mean difference between pre- and postoperative hemoglobin levels were higher in the non-TA group (1.7 g/dL vs 2.6 g/dL, p

Özet

Amaç: Bu çalışmada total diz artroplastisi (TDA) hastalarında eklem içi tranekzamik asit (TA) uygulamasının drenlerdeki kan miktarına, kan transfüzyonu miktarına, hastanede kalış süresine ve toplam maliyete etkisi değerlendirildi.Hastalar ve yöntemler: Çalışmaya TDA cerrahisi uygulanan toplam 118 hasta dahil edildi (24 erkek, 94 kadın; ort. yaş 67.0; dağılım 52-81 yıl). Hastalar eklem kapsülünün kapatılmasının ardından eklem içi 2 g TA uygulanan 58 hasta (TA grubu; 10 erkek, 48 kadın ort. yaş 65.6; dağılım 55-80 yıl) ve herhangi bir eklem içi enjeksiyon uygulanmayan 60 hasta (TA'sız grup; 14 erkek, 46 kadın; ort. yaş 68.3; dağılım 52-81 yıl) olarak iki gruba ayrıldı. Her hastanın ameliyat öncesi ve sonrası hemoglobin düzeyleri arasındaki maksimum farklılık, drenlerdeki kan miktarı, kan transfüzyonu miktarı, hastanede kalış süresi ve maliyeti kaydedildi.Bulgular: Ameliyat öncesi ve sonrası hemoglobin düzeylerindeki ortalama farklılık TA'sız grupta daha yüksek idi (1.7 g/dL'ye karşın 2.6 g/dL, p

🔖

Cite This Article

ACAR, M. A., ERKOÇAK, Ö. F., AYDIN, B. K., DURGUT, F. (2022). Eklem içi tranekzamik asit enjeksiyonunun primer total diz artoplastisindekan transfüzyonu oranlarını azaltmasından başka faydalar. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), Cilt: 28 - Sayı: 1, 25–29. https://ajindex.com/articles/498459

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Eroğlu M, Kokulu S, Koca HB, Demirboğan ME, Baki ED, Özcan Ö. The effects of general and spinal anesthesia on systemic inflammatory response in patients undergoing total knee arthroplasty. Eklem Hastalik Cerrahisi 2016;27:153-9.
  2. Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013;28:137-9.
  3. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty 2013;28:34-7. Atik OS. Does tranexamic acid reduce blood loss and blood transfusion requirement in knee arthroplasty? Eklem Hastalik Cerrahisi 2012;23:166-7.
  4. Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011;35:1639-45.
  5. Çavuşoğlu AT, Ayanoğlu T, Esen E, Atalar H, Turanlı S. Is intraarticular administration of tranexamic acid efficient and safe as systemic administration in total knee arthroplasty? Single center, randomized, controlled trial. [Article in Turkish] Eklem Hastalik Cerrahisi 2015;26:164-7.
  6. Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013;21:1869-74.
  7. Yang Y, Lv YM, Ding PJ, Li J, Ying-Ze Z. The reduction in blood loss with intra-articular injection of tranexamic acid in unilateral total knee arthroplasty without operative drains: a randomized controlled trial. Eur J Orthop Surg Traumatol 2015;25:135-9.
  8. Wang H, Shen B, Zeng Y. Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled and prospective cohort trials. Knee 2014;21:987-93.
  9. Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;28:74-7.
  10. Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 2014;29:1512-5.
  11. Patel JN, Spanyer JM, Smith LS, Huang J, Yakkanti MR, Malkani AL. Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospec